Effect of the Honan intraocular pressure reducer on intraocular pressure increase following intravitreal injection using the tunneled scleral technique

Japanese Journal of Ophthalmology

Volumn 55, Issue 6, 2011, Pages 632-637

  Kim, Kyu Seop ^a   Jee, Donghyun ^b  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Honan intraocular pressure reducer; Intraocular pressure; Intravitreal injection; Vitreous reflux

Indexed keywords

BEVACIZUMAB;

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; CONTROLLED STUDY; DEVICE THERAPY; DIABETIC MACULAR EDEMA; DRUG ADMINISTRATION ROUTE; FEMALE; HONAN INTRAOCULAR PRESSURE REDUCER; HUMAN; INTRAOCULAR PRESSURE ABNORMALITY; MAJOR CLINICAL STUDY; MALE; OPTICAL INSTRUMENTATION; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRESSURE MEASUREMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA MACULA AGE RELATED DEGENERATION; RETINA VEIN OCCLUSION; THERAPY EFFECT; VITREOUS DISEASE;

AGED; ANESTHESIA, LOCAL; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; BALLOON OCCLUSION; FEMALE; HUMANS; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; MALE; MIDDLE AGED; OCULAR HYPERTENSION; PROSPECTIVE STUDIES; SCLERA; SURGICAL FLAPS; TONOMETRY, OCULAR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 82955203471     PISSN: 00215155     EISSN: 16132246     Source Type: Journal    
DOI: 10.1007/s10384-011-0088-1     Document Type: Article

References (35)

1. JB Gunther MM Altaweel 2009 Bevacizumab (Avastin) for the treatment of ocular disease Surv Ophthalmol 54 372 400 19422965
2. C Schmucker C Ehlken LL Hansen G Antes HT Agostini M Lelgemann 2010 Intravitreal bevacizumab (Avastin) vs. ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a systematic review Curr Opin Ophthalmol 21 218 226 20393293
3. S Nghiem-Buffet SY Cohen 2009 Retinal vein occlusion: anti-VEGF treatments J Fr Ophtalmol 32 679 686 19879018 1:STN:280:DC%2BD1Mjos1ehtQ%3D%3D
4. JF Arevalo RA Garcia-Amaris 2009 Intravitreal bevacizumab for diabetic retinopathy Curr Diabetes Rev 5 39 46 19199897 1:CAS:528:DC%2BC3cXislyitL4%3D
5. JS Schouten EC La Heij CA Webers IJ Lundqvist F Hendrikse 2009 A systematic review on the effect of bevacizumab in exudative age-related macular degeneration Graefes Arch Clin Exp Ophthalmol 247 1 11 18843500 1:CAS:528:DC%2BD1cXhtl2qtLjO
6. KM Sampat SJ Garg 2010 Complications of intravitreal injections Curr Opin Ophthalmol 21 178 183 20375895
7. RD Jager LP Aiello SC Patel ET Cunningham Jr 2004 Risks of intravitreous injection: a comprehensive review Retina 24 676 698 15492621 (Pubitemid 39391758)
8. CJ Boon N Crama BJ Klevering FJ van Kuijk CB Hoyng 2008 Reflux after intravitreal injection of bevacizumab Ophthalmology 115 1270 18598829 (author's reply 1271) (Pubitemid 351885413)
9. EB Rodrigues CH Meyer A Grumann Jr H Shiroma JS Aguni ME Farah 2007 Tunneled scleral incision to prevent vitreal reflux after intravitreal injection Am J Ophthalmol 143 1035 1037 17524772 (Pubitemid 46764639)
10. V Sharei F Hohn T Kohler LO Hattenbach A Mirshahi 2010 Course of intraocular pressure after intravitreal injection of 0.05 mL ranibizumab (Lucentis) Eur J Ophthalmol 20 174 179 19927267
11. PB Knecht S Michels V Sturm MM Bosch MN Menke 2009 Tunnelled versus straight intravitreal injection: intraocular pressure changes, vitreous reflux, and patient discomfort Retina 29 1175 1181 19734766
12. EB Rodrigues M Maia FM Penha E Dib AF Bordon O Magalhaes Junior ME Farah 2008 Technique of intravitreal drug injection for therapy of vitreoretinal diseases Arq Bras Oftalmol 71 902 907 19169531
13. L Lopez-Guajardo FG Del Valle JP Moreno MA Teus 2008 Reduction of pegaptanib loss during intravitreal delivery using an oblique injection technique Eye (Lond) 22 430 433 1:CAS:528:DC%2BD1cXjt1Cqsbg%3D (Pubitemid 351404471)
14. F Hohn A Mirshahi 2010 Impact of injection techniques on intraocular pressure (IOP) increase after intravitreal ranibizumab application Graefes Arch Clin Exp Ophthalmol 248 1371 1375 20407785
15. M Gismondi C Salati ML Salvetat M Zeppieri P Brusini 2009 Short-term effect of intravitreal injection of ranibizumab (Lucentis) on intraocular pressure J Glaucoma 18 658 661 20010243
16. JP Hubschman RE Coffee JL Bourges F Yu SD Schwartz 2010 Experimental model of intravitreal injection techniques Retina 30 167 173 19779317
17. RT Cortez G Ramirez L Collet P Thakuria GP Giuliari 2010 Intravitreous bevacizumab injection: an experimental study in New Zealand white rabbits Arch Ophthalmol 128 884 887 20625050 1:CAS:528:DC%2BC3cXpvVeksLg%3D
18. JH Vallance N Patton A Ferguson HG Bennett 2004 Effect of the Honan intraocular pressure reducer in sub-Tenon's anesthesia J Cataract Refract Surg 30 433 436 15030837 (Pubitemid 38366371)
19. DA Palay RD Stulting 1990 The effect of external ocular compression on intraocular pressure following retrobulbar anesthesia Ophthalmic Surg 21 503 507 2399001 1:STN:280:DyaK3cznslCqtQ%3D%3D (Pubitemid 20268225)
20. MS Benz TA Albini ER Holz RR Lakhanpal AC Westfall MN Iyer PE Carvounis 2006 Short-term course of intraocular pressure after intravitreal injection of triamcinolone acetonide Ophthalmology 113 1174 1178 16647122 (Pubitemid 43947221)
21. Z He BV Bui AJ Vingrys 2008 Effect of repeated IOP challenge on rat retinal function Invest Ophthalmol Vis Sci 49 3026 3034 18326699
22. TA Wingert CJ Bassi WH McAlister JC Galanis 1995 Clinical evaluation of five portable tonometers J Am Optom Assoc 66 670 674 8576531 1:STN:280:DyaK287hs1Kguw%3D%3D
23. H Murase A Sawada K Mochizuki T Yamamoto 2009 Effects of corneal thickness on intraocular pressure measured with three different tonometers Jpn J Ophthalmol 53 1 6 19184301
24. GF Chiara LP Semes JW Potter GR Cutter WR Tucker 1989 Portable tonometers: a clinical comparison of applanation and indentation devices J Am Optom Assoc 60 105 110 2703651 1:STN:280:DyaL1M7pvVehtQ%3D%3D
25. MP Frenkel SA Haji RE Frenkel 2010 Effect of prophylactic intraocular pressure-lowering medication on intraocular pressure spikes after intravitreal injections Arch Ophthalmol 128 1523 1527 21149773
26. Knip MM, Valimaki J. Effects of pegaptanib injections on intraocular pressure with and without anterior chamber paracentesis: a prospective study. Acta Ophthalmol. 2010. doi: 10.1111/j.1755-3768.2010.01904.x
27. BC Joondeph HC Joondeph 1986 Purulent anterior segment endophthalmitis following paracentesis Ophthalmic Surg 17 91 93 3485783 1:STN:280: DyaL287ns1Sisg%3D%3D (Pubitemid 16130790)
28. JM Lin YY Tsai YT Chiu PT Hung 2006 Paracentesis before or after intravitreal injection of triamcinolone acetonide and its necessity? Am J Ophthalmol 141 985 986 16678539 (author reply 986)
29. A Van der Lelij A Rothova 1997 Diagnostic anterior chamber paracentesis in uveitis: a safe procedure? Br J Ophthalmol 81 976 979 9505822 (Pubitemid 27493985)
30. MC Hernaez-Ortega E Soto-Pedre 2008 Intravitreal injection of triamcinolone acetonide and intraocular pressure Acta Ophthalmol 86 693 18752520
31. A Azuara-Blanco LJ Katz 1997 Infectious keratitis in a paracentesis tract Ophthalmic Surg Lasers 28 332 333 9101576 1:STN:280:DyaK2s3ls1antw%3D%3D
32. H Helbig W Noske M Kleineidam U Kellner MH Foerster 1995 Bacterial endophthalmitis after anterior chamber paracentesis Br J Ophthalmol 79 866 7488613 1:STN:280:DyaK28%2Fps1WgtA%3D%3D
33. K Green D Harman L Cheeks 1986 The interrelationship between intraocular pressure and Honan intraocular pressure reducer pressure Curr Eye Res 5 621 623 3757548 1:STN:280:DyaL2s%2FgtlKisQ%3D%3D (Pubitemid 17173737)
34. PJ McDonnell HA Quigley AE Maumenee WJ Stark GM Hutchins 1985 The Honan intraocular pressure reducer. An experimental study Arch Ophthalmol 103 422 425 3977718 1:STN:280:DyaL2M7kvVOgsA%3D%3D (Pubitemid 15137045)
35. MC Hernaez-Ortega E Soto-Pedre 2007 Use of the Honan balloon as a compression device for intravitreal triamcinolone acetonide injection Ophthalmic Surg Lasers Imaging 38 87 88 17278546 (Pubitemid 46207338)